Pep1

General Information


DRACP ID  DRACP00194

Peptide Name   Pep1

Sequence  FKCRRWQWRMKKLGAPSITCVR

Sequence Length  22

UniProt ID  P24627 

PubChem CID  Not available

Origin  Bovine lactoferrin (Lf-B)

Type  Native peptide

Classification

  

Active ACP



Activity Information


Cell Line Disease Cancer Classified Activity Assay Testing Time Literature
HL-60 Adult acute myeloid leukemia; Acute myeloid leukemia Leukemia IC50=77 µM MTS assay 24 h 1

Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Pep1 may kill cancer cells by activating an apoptosis-inducing pathway

Nature  Anticancer; Antimicrobial



Structure Information


PDB ID  1LFC 

Predicted Structure  DRACP00194

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C123H200N40O26S3

Absent amino acids  DEHNY

Common amino acids  R

Mass  312612

Pl  12.1

Basic residues  7

Acidic residues  0

Hydrophobic residues  7

Net charge  7

Boman Index  -5866

Hydrophobicity  -65.91

Aliphatic Index  53.18

Half Life 
  Mammalian: 1.3 hour
  Yeast: 3 min
  E.coli: 2 min

Extinction Coefficient cystines  11125

Absorbance 280nm  529.76

Polar residues  5

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 18425992

Title  A lactoferrin-derived peptide with cationic residues concentrated in a region of its helical structure induces necrotic cell death in a leukemic cell line (HL-60)

Doi 10.1002/psc.1039

Year  2008

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DRACP is developed by Dr.Zheng's team.